Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 213 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1311 | 0.970 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 140 | 0.820 |
Why?
|
| Brain Mapping | 6 | 2021 | 190 | 0.810 |
Why?
|
| Blood Glucose | 2 | 2020 | 120 | 0.810 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.690 |
Why?
|
| Biomarkers | 3 | 2020 | 733 | 0.690 |
Why?
|
| Headache | 1 | 2019 | 43 | 0.670 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.640 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 29 | 0.630 |
Why?
|
| Lymphocytes | 1 | 2018 | 111 | 0.620 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.570 |
Why?
|
| Sclerosis | 1 | 2017 | 71 | 0.560 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 50 | 0.550 |
Why?
|
| Temporal Lobe | 1 | 2017 | 103 | 0.540 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 105 | 0.520 |
Why?
|
| Thalamus | 4 | 2021 | 24 | 0.510 |
Why?
|
| Image Enhancement | 2 | 2020 | 60 | 0.500 |
Why?
|
| Middle Aged | 22 | 2021 | 10192 | 0.480 |
Why?
|
| Adult | 22 | 2021 | 8924 | 0.480 |
Why?
|
| Female | 28 | 2021 | 16965 | 0.480 |
Why?
|
| Humans | 44 | 2022 | 30959 | 0.480 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 85 | 0.450 |
Why?
|
| Male | 27 | 2021 | 16425 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1800 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 81 | 0.400 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 90 | 0.370 |
Why?
|
| Aged | 15 | 2021 | 10047 | 0.340 |
Why?
|
| Brain Ischemia | 2 | 2021 | 75 | 0.340 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 13 | 0.330 |
Why?
|
| Motor Cortex | 1 | 2009 | 17 | 0.330 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 119 | 0.310 |
Why?
|
| Young Adult | 6 | 2021 | 2060 | 0.310 |
Why?
|
| Brain Diseases | 1 | 2009 | 82 | 0.310 |
Why?
|
| Graft Rejection | 2 | 2018 | 74 | 0.290 |
Why?
|
| Liver Transplantation | 2 | 2018 | 80 | 0.280 |
Why?
|
| Contrast Media | 3 | 2020 | 136 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1009 | 0.270 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.260 |
Why?
|
| Case-Control Studies | 4 | 2021 | 660 | 0.250 |
Why?
|
| Language | 1 | 2005 | 79 | 0.250 |
Why?
|
| Risk Factors | 7 | 2021 | 2586 | 0.240 |
Why?
|
| Sex Characteristics | 1 | 2005 | 144 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 991 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 133 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 35 | 0.210 |
Why?
|
| Turkey | 2 | 2018 | 5 | 0.200 |
Why?
|
| Radiology | 1 | 2021 | 22 | 0.190 |
Why?
|
| Encephalocele | 1 | 2021 | 32 | 0.190 |
Why?
|
| Patient Care Planning | 1 | 2001 | 58 | 0.190 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 43 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3658 | 0.190 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.180 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.180 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 39 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 69 | 0.180 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2020 | 15 | 0.180 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 13 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 115 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 23 | 0.180 |
Why?
|
| Glioma | 1 | 2021 | 54 | 0.180 |
Why?
|
| Nerve Net | 1 | 2021 | 51 | 0.180 |
Why?
|
| Dissection | 1 | 2020 | 27 | 0.180 |
Why?
|
| Gray Matter | 1 | 2021 | 59 | 0.180 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 7 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 37 | 0.180 |
Why?
|
| Hospital Mortality | 1 | 2021 | 148 | 0.180 |
Why?
|
| Artifacts | 1 | 2020 | 33 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 135 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 181 | 0.170 |
Why?
|
| Fasting | 1 | 2019 | 13 | 0.170 |
Why?
|
| Hernia | 1 | 2019 | 8 | 0.170 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 10 | 0.170 |
Why?
|
| Brain Edema | 1 | 2019 | 23 | 0.170 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 121 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 157 | 0.170 |
Why?
|
| Emergencies | 1 | 2019 | 40 | 0.170 |
Why?
|
| Movement | 1 | 2020 | 137 | 0.170 |
Why?
|
| Acute Disease | 2 | 2019 | 231 | 0.170 |
Why?
|
| Sarcoidosis | 1 | 2019 | 14 | 0.170 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 23 | 0.170 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 9 | 0.160 |
Why?
|
| Recovery of Function | 1 | 2020 | 298 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 194 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 24 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 53 | 0.160 |
Why?
|
| Stomach | 1 | 2018 | 19 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 35 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 35 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 33 | 0.160 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 21 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 45 | 0.160 |
Why?
|
| Brain Abscess | 1 | 2018 | 7 | 0.160 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 44 | 0.160 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 12 | 0.160 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 22 | 0.160 |
Why?
|
| Weight Gain | 1 | 2019 | 70 | 0.160 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 48 | 0.150 |
Why?
|
| Walking | 1 | 2020 | 259 | 0.150 |
Why?
|
| Child Development | 1 | 2019 | 71 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 14 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 2399 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 33 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 148 | 0.150 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 207 | 0.150 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 7 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 2019 | 155 | 0.150 |
Why?
|
| Biliary Tract | 1 | 2017 | 2 | 0.150 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.150 |
Why?
|
| Cysts | 1 | 2017 | 16 | 0.150 |
Why?
|
| Pregnancy | 1 | 2019 | 404 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 230 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 10 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 32 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 41 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 225 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 125 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 50 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 3 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 5 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 240 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 817 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2017 | 88 | 0.140 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 376 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 583 | 0.140 |
Why?
|
| Aged, 80 and over | 6 | 2021 | 5189 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1897 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 260 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 382 | 0.130 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 60 | 0.130 |
Why?
|
| Child | 3 | 2021 | 1428 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 315 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 20 | 0.120 |
Why?
|
| Corpus Callosum | 2 | 2019 | 14 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 230 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 562 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 919 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2018 | 1069 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1672 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1922 | 0.090 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 44 | 0.090 |
Why?
|
| Neuroradiography | 1 | 2009 | 3 | 0.080 |
Why?
|
| Aging | 1 | 2019 | 1727 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 407 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 549 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 36 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 5 | 0.080 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 228 | 0.080 |
Why?
|
| Hospitalization | 2 | 2021 | 336 | 0.080 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 6 | 0.080 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 9 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 429 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 7 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 98 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 716 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 404 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 817 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 452 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2006 | 82 | 0.070 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1505 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 15 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 15 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 25 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 44 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 83 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 689 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 15 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3806 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 7 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 6 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 5 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 33 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 500 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 22 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2020 | 46 | 0.050 |
Why?
|
| Fatigue | 1 | 2020 | 66 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 12 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 49 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 27 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2020 | 113 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 55 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 5 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 132 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 510 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 9 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 11 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 25 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 10 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 25 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 36 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 70 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 162 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 145 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 115 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 68 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 60 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 11 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 197 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 144 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 150 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 578 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 3 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2019 | 637 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 339 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 184 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 3 | 0.030 |
Why?
|
| Exercise | 1 | 2020 | 507 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 76 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 13 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 14 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 697 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 26 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 420 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 2 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 5 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 428 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 11 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2373 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 12 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 17 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 51 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 219 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 378 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 4 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 15 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 3 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 6 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 45 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 104 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 59 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 85 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 120 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 217 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 873 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 36 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 46 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 271 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 691 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 4722 | 0.010 |
Why?
|